"10.1371_journal.pone.0143558","plos one","2015-11-25T00:00:00Z","Paul Gozzard; Caroline Chapman; Angela Vincent; Bethan Lang; Paul Maddison","Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; Division of Medical Sciences & Graduate Entry Medicine, University of Nottingham, Royal Derby Hospital, Derby, United Kingdom; Division of Clinical Neuroscience, University of Nottingham, Queen’s Medical Centre, Nottingham, United Kingdom","Conceived and designed the experiments: PG CC AV BL PM. Performed the experiments: PG CC BL. Analyzed the data: PG AV BL. Contributed reagents/materials/analysis tools: PG CC AV BL. Wrote the paper: PG AV BL PM.","Dr Chapman reports grants and receives personal fees from OncoImmune Inc. Prof Vincent reports grants from NIHR and receives personal fees from Athena diagnostics. Prof Vincent is the named inventor on patent application WO/2010/046716 entitled ‘Neurological autoimmune disorders’. The patent has been licensed to Euroimmun AG for the development of assays for LGI1 and other VGKC-complex antibodies. Dr Lang is a coinventor and may also receive future royalties. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials. The authors have no other relevant declarations relating to employment, consultancy, patents, products in development or modified products. The other authors have declared that no competing interests exist.","2015","11","Paul Gozzard","PG",5,FALSE,5,3,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
